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INTRODUCTION:
There is a critical need for basic research to discover new methods that would improve the outcomes of soldiers who incur battlefield wounds. Initially, most war wounds are colonized by Gram-positive bacteria. However, after initial stabilization and surgery, residual infections in open wounds are characterized by predominantly Gram-negative bacteria including Acinetobacter baumannii-calcoaceticus complex, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Additionally, wounded soldiers have a very high rate of hospital-acquired infections by such pathogens as Staphylococcus aureus. Thus, war wounds remain susceptible to infection from the time of injury through subsequent surgery, therapy, and rehabilitation and often contain multiple bacterial species. Moreover, each of these organisms has different resistance patterns to antibiotics, further limiting treatment options. Often, even broad-spectrum antibiotics are not sufficient to eradicate all of the organisms contained within a wound.
While bacterial pathogenesis mechanisms, virulence factors, and antimicrobial resistance vary greatly between pathogens associated with war wounds, one common trait shared by all is the ability to colonize wounds as a biofilm (see figure) . Biofilms are formed when planktonic bacteria (i.e., free, individual cells) adsorb onto a wound surface and form multi-cellular colonies (figure, stage 1).
Once the colonies become established, phenotypic changes cause them to secrete polysaccharides that serve as the backbone for the biofilm (figure, stage 2 and 3). Non-cellular components and debris, including additional carbohydrates, proteins, lipids, and nucleic acids, become entangled in the polysaccharide backbone and constitute the extrapolymeric substance (EPS) or "slime" layer of a biofilm ( figure, stage 4) . Significantly, the superstructure of the biofilm is known to protect internal bacteria from antimicrobials, antibodies, and circulating immune cells (figure, stage 5). Thus, approaches that disrupt or dissolve the biofilm superstructure of polymicrobial infections would offer a therapeutic avenue to reduce the morbidity and mortality associated with war wounds by "re-sensitizing" the bacteria to antibiotics and the soldier's immune system.
To accomplish this goal, we will use special enzymes called depolymerases. Depolymerases are normally found on the surface of bacterial viruses (i.e. bacteriophage) where they function to dissolve the EPS layer on naturally occurring biofilms allowing the phage to invade the bacterial cell. We plan to identify and test many such depolymerases to find the best enzyme, or cocktail of enzymes, that will dissolve biofilms associated with the bacteria that infect war wounds. Although the depolymerases do not directly kill the bacteria, it is believed that dissolution of the biofilm protective layer will allow common antibiotics or the immune system to clear the infection.
BODY:
Specific Aim 1. Identify, clone, and express potential depolymerases.
Task 1. IACUC and USAMRMC ACURO review and approval of animal regulatory documents (months 1-4)
I submitted my paperwork to complete this task, but it was placed in the deferred review queue by Ms. Teresa Kuykendal, Administrative Assistant, Animal Care and Use Review Office (ACURO). Because the animal experiments do not take place until year 3 of the award, ACURO did not want to review my request as it is possible that protocols could expire or change during the time between review and actual animal experimentation. Thus, this task remains under deferred review. I will resubmit the paperwork around the 24th month of the project, which should be enough time for proper review before any animal experiments begin.
Task 2. Bioinformatic analysis. (months 1-3)
The bioinformatic component was more difficult than we thought and actually took much of the first year to complete. It began by manually analyzing each and every gene from ~700 fully sequenced phage genomes. Below is just an example for illustrative purposes of one phage that infects Pseudomonas species:
ID: Pseudomonas phage 201phi2-1 Genes: 461
We used hierarchical clustering algorithms (i.e. DomClust) as well as online biofinformatics tools such as the Clusters of Orthologous Groups (COGs) of proteins available through the National Center for Biotechnology Information (NCBI, http://www.ncbi.nlm.nih.gov) to analyze the phage genomes. For this genome, we identified 20 unique domain clusters as follows:
Of these 29 protein domain clusters, the following were identified as potential domains that might contain a depolymerase-like activity:
1.
CLSP32357-cl11427(Polysacc_deac_1), a putative polysaccharide deacetylase with putative alpha-mannosidase activity 2.
CLSP32360-cl04270(Glyco_transf_WecG_TagA), a putative UDP-N-acetyl-Dmannosaminuronic acid transferase 3.
CLSP30732-cd00254(LT_GEWL), a putative lytic transglycosylase or goose egg white lysozyme
Of the three, only CLSP32357 appeared to contain an activity that would work against polysaccharides known to be present in a Pseudomonas biofilm.
Despite the successful identification of one putative depolymerase in the example above, the bioinformatic analysis was cumbersome and yielded relatively few candidate enzymes. This is due in part to the relatively low numbers of known depolymerase genes. However, I then attended a "Phage RAST (Rapid Annotation using Subsystem Technology) Jamboree" session in Tuscon, Arizona at the end of January 2011. This meeting brought together the top bioinformatics scientists in the nation and paired them with phage experts in order to rapidly identify and annotate unedited sequences in the databases that belong to phage genomes. I was invited as a "phage expert" for my knowledge about phage lytic enzymes. However, while I was there, I was able to tap the expertise of the bioinformaticists and search for novel depolymerase enzymes.
In a significant breakthrough, our bioinformatics analysis revealed a class of phage-derived enzymes that may be the "archetypical" depolymerase. This protein, also called a "tailspike" protein, is present on a family of bacteriophage called Podoviridae, or phage with short, noncontractile tails. In the cryo-electron image below (taken from Casjens and Thuman-Commike, 2011), the tailspike protein is shown as gp9. Notably, tailspike proteins self assemble into active trimers that are resistant to detergent and heat, which is favorable for a therapeutic protein.
These enzymes cleave the extracellular polysaccharide of the host bacterial species, which form the backbone of the extrapolymeric substance (EPS) associated with biofilm development.
Below is a figure of the unrooted neighborjoining tree of the P22-like tailspike proteins (adapted from Casjens and Thuman-Commike, 2011). The phage names are colored according to their host species as follows: Escherichia, red; Salmonella, black; Shigella, blue; Providencia, orange; Pectobacterium, purple; Hamiltonella, green; Sodalis, gray. Outside of the tree, the polysaccharide repeats of the host are displayed where known (Glc, glucose; Man, mannose; Rha, rhamnose; Gal, galactose; Abeq, abequose; Tyvel, tyvelose; Para, paratose; Col, colitose; GlcNAc, N-acetyl-glucosamine; ManOAc, Oacetyl-mannose; GalOAc, O-acetyl-galactose).
As can be seen, there is a broad diversity in the polysaccharides that are cleaved by these proteins. One challenge we face is narrowing down the list of potential depolymerases that will presumably cleave the polysaccharides of our target organisms associated with war wounds (i.e., Acinetobacter baumannii-calcoaceticus complex, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Staphylococcus aureus). Therefore, we developed a two-pronged approach. First, because many of these polysaccharides are likely to occur in biofilms of war wound pathogens, we selected 10 tailspike proteins from the above figure for gene synthesis and evaluation. Second, we re-focused our bioinformatic search to phage belonging to the Podoviridae family that infect war wound pathogens. Below is a complete list of Podoviridae phage for Psuedomonas, Klebsiella, and Staphylococcus species as identified by our bioinformatic analysis. Any tailspike proteins contained in these phage will be synthesized after we complete a near neighbor tree to rule out any overlapping tailspikes. Based on our two-pronged bioinformatics approach, we have already synthesized 10 genes and are currently synthesizing 5 more. We are waiting on preliminary characterization of the first 10 genes to determine which enzymes possess the best anti-biofilm properties. If we find one or two that are significantly better than the rest, we will then synthesize ~5 additional genes based on othrologs that have already been identified by bioinformatic analysis. For illustration purposes, a representative sample of 4 genes is shown below. Each gene sequence was optimized for codon-usage and expression in an E. coli host. Additionally, 6X-His tags were added to the 5-prime ends for purification purposes. All gene inserts were cloned into a pBAD24 expression vector between the XbaI and EcoRI restriction sites. If these sites were present in the insert, we mutated them based on alternative codons in order to remove the restriction site from the insert.
Task 4. Obtain phage from international collections for depolymerase screening. (months 1-3)
We have assembled a limited phage collection from various repositories for depolymerase screening. In addition, we possess a fairly large collection of our own phage. However, we believe the majority of novel depolymerases will be found from bioinformatic analysis of databases rather than screening individual phages.
Task 5. Clone depolymerases from phage. (months 2-6)
Because most, if not all, of the depolymerases were identified by bioinformatic analysis, we have not cloned any depolymerases from our current repertoire of phage. As an aside, the phage we have on hand are all sequenced and as such, are already represented in the bioinformatic analysis.
The tailspike proteins, which we identified as the most likely candidate for the depolymerase activity we seek, are only associated with phage that belong to the Podoviridae family. While we have identified numerous Podoviridae phage and tailspike proteins affiliated with Pseudomonas, Klebsiella, Escherichia, and Staphylococcus species, there are no known Acinetobacter phage that belong to the Podoviridae family (the known Acinetobacter phage are members of the Myoviridae or Siphoviridae families, which typically do not contain tailspike proteins). Nonetheless, we are confident that the extraction and characterization of the Acinetobacter polysaccharide (i.e. Aim 2) will reveal that many components and linkages that are identical to many of the other Gram-negative organisms, for which there are Podoviridae phage and tailspike proteins. If this is not the case, we will screen sewage and other environmental sources for novel Acinetobacter phage that are members of the Podoviridae family.
Task 6. Express and purify all assembled depolymerase enzymes. (months 3-14)
We currently have 10 genes cloned and another 5 being synthesized. Of the 10 clones, 4 of them formed insoluble inclusion bodies. Attempts to refold these proteins (i.e. denature in 8 M urea and refold on an anion exchange column) did not prove successful. The other six proteins were expressed at high levels and displayed good solubility properties. The purification of three of them (Dsp, top; Sf6, middle; and Betty, bottom) on a nickel column are shown on the right. For all gels: Lane 1 -markers; lane 2 -extract; lane 3 -column flow through; lanes 4,5 -wash; lanes 6,7,8 -imidizole elution.
For one protein, CBA_120, the enzyme was soluble, but did not bind the column. We denatured the protein in 6M urea and showed that it did bind to the column, so it had the proper 6XHis tag. Therefore, we surmised that the His tag was buried in a globular fold of the protein.
To address this problem, we removed the N-terminal His tag and placed a C-terminal His tag though point mutagenesis techniques. The new protein remained soluble, bound to the nickel column, and was purified to homogeneity similar to the other proteins.
Although characterization of the depolymerases is not scheduled to occur until months 18-24, we nonetheless wanted to assay our enzymes for activity as soon as we purified them. As an example, the enzyme SL-Dsp is a putative glucoasminidase. The synthetic substrate, 4-Nitrophenyl N-acetyl-b-D-glucosaminide, releases the nitrophenyl chromophore when cleaved by a glucosaminidase which can easily be monitored by a spectrophotometer by as an increase in yellow color over time. The image below shows the activity of this enzyme in increasing concentration.
Specific Aim 2. Characterize biofilm polysaccharide composition.
Task 1. Collect biofilm EPS. (months 6-12)
Much of this Task involved obtaining the bacterial strains and determining the best growth conditions for biofilm expression. Toward this end, we acquired the following strains: As can be seen, many of these strains have multiple drug resistance (MDR), expanded spectrum beta-lactamase (ESBL) resistance, vancomycin resistance (Van r ), or are methicillan resistant Staphylococcus aureus (MRSA). In addition, several are military isolates, known to be associated with epidemic outbreaks, or are known biofilm producers.
Once the collection was assembled, we had to determine which strains yield the most abundant biofilms, as we need as much biomass as possible in order to extract and analyze the biofilm polysaccharide backbone. We have tested both static and dynamic biofilms as well as different types of media, additives, and pH. Below is just one representative experiment where static biofilms made in tryptic soy broth were compared. As can be seen, several strains generated significant biofilms. Surprisingly, some strains that are known biofilm producers did not produce biofilms under these experimental conditions (See #5, #11, and #13 below). However, under different conditions, they did produce copious biofilms. We ended up selecting the top 2 biofilms producing strains for each organism for extraction. Next, we select a method for EPS extraction. The traditional method (going back to the 1950's) is based on phenol/chloroform and heat. However, more recent methods have showed advantages such as higher yields and a more homogeneous preparation. These include the method of Liu and Fang (2002) that employs NaOH extraction and the method of Oliveira, Biofilm OD Marques, and Azeredo (1999) that uses a 20% solution of trichloroacetic acid. In our hands, the NaOH extraction gave the highest yield of carbohydrate but the trichloroacetic acid method gave the least protein contamination. We chose the trichloroacetic acid method followed by neutralization with NaOH and then gel filtration for final purification. All biofilm polysaccharides were lyophilized for composition (Task 2) and linkage (Task 3) analysis to be accomplished during months 12-18. Polysaccharide yields were ~50 to 100 mg/L depending on strain.
KEY RESEARCH ACCOMPLISHMENTS:
 Determined that phage tailspike proteins most likely represent the identity of the depolymerase enzymes associated with anti-biofilm properties  Successfully synthesized, expressed, and purified 6 putative depolymerase enzymes  Demonstrated enzymatic activity of one of these enzymes  Experimentally determined the optimal growth conditions for biofilm expression  Experimentally determined the optimal method for extraction of biofilm EPS
REPORTABLE OUTCOMES:
Some aspects of our preliminary data and/or overall strategy have been presented at the following meetings/symposia during the past year:
SUPPORTING DATA:
Figures and figure legends are contained within the body of the text above.
